OWPC · XBRL financial data

One World Products financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (OWPC's year ends in late December)

In thousands of dollars	Q4 FY22Dec 31, 2022	Q1 FY23Mar 31, 2023	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025
Revenue from contracts with customers	49*	2	0	6	(0)*	0	1	2	2*	1	0	50
Cost of goods and services sold	year only	1	0	1	171*	0	0	0	0*	0	0	1
Gross profit	—	1	(0)	5	(172)*	0	1	1	1*	1	0	49
General and administrative	439*	347	418	142	382*	199	151	203	101*	99	87	17
Total operating expenses	498*	459	500	388	569*	778	374	373	351*	127	171	426
Operating income (loss)	(694)*	(458)	(500)	(383)	(740)*	(777)	(373)	(372)	(350)*	(126)	(171)	(377)
Interest income	(0)*	—	0	0	0*	—	—	—	—	—	—	—
Interest expense	70*	58	52	68	132*	102	369*	341*	282*	130	87*	258
Net income (loss)	(764)*	(516)	(547)	(450)	(2,440)*	(1,701)	(865)	(735)	(634)*	(256)	(266)	5,266
Earnings per share, basic USD per share	(0.01)*	(0.01)	(0.01)	(0.01)	(0.03)*	(0.02)	(0.01)	(0.01)	(0.01)*	0.00	(0.00)	0.04
Earnings per share, diluted USD per share	—	(0.01)	(0.01)	(0.01)	(0.03)*	(0.02)	(0.01)	(0.01)	(0.01)*	0.00	(0.00)	0.04
Weighted average shares, basic thousands of shares	67,203*	68,703	70,578	74,958	78,968*	86,930	112,565	113,618	114,615*	117,245	117,939	118,775
Weighted average shares, diluted thousands of shares	67,203*	68,703	70,578	74,958	78,968*	86,930	112,565	113,618	114,615*	117,245	117,939	118,775

Fiscal quarters (OWPC's year ends in late December)

In thousands of dollars	Q4 FY22Dec 31, 2022	Q1 FY23Mar 31, 2023	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025
Cash and cash equivalents	11	85	175	10	1	41	362	82	42	0	14	169
Accounts receivable	12	11	12	12	—	0	—	0	0	0	—	46
Inventory	54	279	303	313	—	26	18	17	16	12	12	67
Total current assets	123	448	613	361	14	99	418	115	68	25	226	305
Property and equipment, net	989	2,385	2,377	2,367	—	—	—	—	—	—	—	6,317
Right-of-use asset	426	404	—	—	—	—	—	—	—	—	—	—
Total assets	3,168	3,474	3,246	3,027	99	184	578	275	68	25	226	6,621
Accounts payable	798	748	819	816	529	619	536	575	594	615	623	707
Accrued liabilities	948	1,120	1,276	1,238	939	872	962	1,056	651	772	798	873
Total current liabilities	2,977	3,118	3,661	4,513	3,872	1,971	2,925	3,270	3,169	3,376	3,424	4,258
Lease liability, non-current	342	319	—	—	—	—	—	—	—	—	—	—
Total liabilities	4,219	4,336	4,411	4,513	3,872	4,412	5,162	5,360	5,255	5,463	5,923	7,067
Accumulated deficit	(22,976)	(23,492)	(24,039)	(24,490)	(26,930)	(28,631)	(29,496)	(30,230)	(30,865)	(31,120)	(31,386)	(26,121)
Total stockholders' equity	(5,836)	(5,842)	(6,244)	(6,211)	(8,348)	(8,803)	(9,159)	(9,809)	(9,912)	(10,163)	(10,421)	(5,170)
Total liabilities and equity	3,168	3,474	3,246	3,027	99	184	578	275	68	25	226	6,621
Common shares outstanding (cover page) thousands of shares	70,203	73,370	74,736	78,308	104,330	104,330	105,012	105,891	109,226	110,109	110,109	120,109

Fiscal quarters (OWPC's year ends in late December)

In thousands of dollars	Q4 FY22Dec 31, 2022	Q1 FY23Mar 31, 2023	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025
Net income (loss)	(764)*	(516)	(547)	(450)	(2,440)*	(1,701)	(865)	(735)	(634)*	(256)	(266)	5,266
Stock-based compensation	0*	38	35*	48*	—	4	4*	4*	—	—	—	—
Depreciation and amortization	8*	8	8*	9*	9*	—	—	—	year only	—	—	—
Net cash from operating activities	(256)*	(562)	(281)*	(200)*	(151)*	(250)	(480)*	(281)*	(111)*	(52)	(397)*	(145)*
Purchases of property and equipment	0*	5	0*	0*	0*	—	—	—	—	—	—	—
Net cash from investing activities	0*	(5)	0*	0*	0*	—	—	0*	0*	—	—	—
Proceeds from issuing common stock	200*	450	100*	0*	100*	—	—	—	0*	—	—	—
Net cash from financing activities	200*	450	363*	62*	185*	332	877*	0*	72*	10	410*	715*
Net change in cash	(58)*	74	91*	(165)*	(9)*	40	322*	(281)*	(39)*	(42)	13*	155*

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
One World Products	169	50	(145)*	120.1M	1.2 quarters	Q3 FY25 10-QSep 30, 2025
Regen BioPharma	0.2	59	(24)*	1.7B	0.0 quarters	Q3 FY26 10-QJun 30, 2026
Zivo Bioscience	57	66	(267)*	3.9M	0.2 quarters	Q3 FY25 10-QSep 30, 2025
Nutra Pharma	not reported	34	(251)*	7.2B	0.1 quarters	Q2 FY26 10-QJun 30, 2026
Vyome Holdings	7,888	27	(904)*	7.0M	8.7 quarters	Q2 FY26 10-QJun 30, 2026
America Great Health	29	26	1.7*	21.2B	—	Q3 FY26 10-QMar 31, 2026
AIM ImmunoTech	9,900	26	(4,590)*	30.4M	2.2 quarters	Q2 FY26 10-QJun 30, 2026
Yarrow Bioscience	22,925	97	(1,992)*	2.7M	11.5 quarters	Q2 FY26 10-QJun 30, 2026
Cardiff Oncology	9,197	104	(11,765)*	77.8M	2.9 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.